Thursday, November 5, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Asian Markets

Apple’s Supply-Chain Squeeze Overshadows Record Quarter as Leadership Handoff Looms

Rodolfo Hanigan by Rodolfo Hanigan
August 6, 2026
in Asian Markets, Semiconductors, Tech & Software
0
Apple Stock
0
SHARES
156
VIEWS
Share on FacebookShare on Twitter

The numbers were pristine. The optics were anything but.

Apple delivered its strongest June quarter on record, yet investors responded by sending the stock down as much as 8 percent in after-hours trading. The disconnect between the headline figures and the market’s reaction tells a more complicated story — one that involves a Chinese memory-chip supplier refusing to play ball, a billion-dollar logjam at TSMC, and a CEO transition that could hardly come at a more awkward moment.

Record Revenue Meets a Rare Stumble in Negotiating Power

For decades, Apple dictated terms to its suppliers and they nodded along. That dynamic has shifted in a way that goes beyond a single procurement dispute. Changxin Memory Technologies (CXMT) has flatly refused Apple’s demands for price concessions on DRAM chips, insisting instead on terms comparable to what Samsung and SK Hynix receive. The Chinese manufacturer can afford to be picky — Huawei and Xiaomi are offering better volume commitments.

The consequences are already visible on the factory floor. TSMC continues to produce Apple’s new A20 Pro chip on schedule, but without sufficient DRAM modules, finished iPhone units can’t be assembled. The foundry is now sitting on roughly $1 billion worth of processors that can’t be packaged, and Apple’s inventory buffer has ballooned from a lean 7 days to 87 days. This isn’t ordinary supply-chain noise; it’s a structural bottleneck.

The Cost of Memory: Margins Under Pressure

The financial impact is starting to show. Reports indicate that prices for certain memory components have surged by as much as 490 percent — a cost shock that tests even Apple’s famously robust margins. Tim Cook has publicly acknowledged the constraints, and the company has already postponed the M5 Mac Mini and Mac Studio as a result.

The third-quarter results themselves were undeniably strong. Revenue climbed 16 percent year over year to $109.4 billion, with earnings per share up 29 percent to $2.02 and net income rising 27 percent to $29.8 billion. The iPhone segment grew 22 percent to $54.3 billion, Mac sales jumped 29 percent, and services — the growth engine investors have watched closely for years — expanded 12 percent to $30.7 billion. Gross margin improved from 46.5 percent to 50.1 percent. On paper, a nearly flawless quarter.

But Cook conceded that Apple simply cannot produce fast enough to meet demand. Inventory reserves are depleted, wait times are lengthening, and prices are rising — particularly for the iPhone 17 and MacBook Neo. Analysts also point to disappointment in China as an additional headwind.

A Leadership Transition at an Inopportune Moment

The share-price reaction lands just as Apple prepares for a changing of the guard. Cook hands the CEO title to John Ternus on September 1, a transition that places the incoming chief under immediate scrutiny amid slowing growth and a demanding valuation. The combination of heavy investment in artificial intelligence and constrained free cash flow adds another layer of difficulty — Apple’s AI strategy is consuming capital while its monetization of AI features appears to lag competitors.

Should investors sell immediately? Or is it worth buying Apple?

The first major test under Ternus arrives quickly. A product event is expected on September 9, where Apple is anticipated to unveil the iPhone 18 Pro and Pro Max. A foldable device, internally referred to as the iPhone Ultra, is also under discussion, potentially priced around $2,000 and featuring the A20 Pro chip and a variable aperture. The standard iPhone 18 may not follow until spring 2027.

Legal Battles and Regulatory Headaches

Meanwhile, Apple is fighting on multiple other fronts. On August 6, 2026, OpenAI moved to dismiss Apple’s trade-secret lawsuit, which alleges that over 400 engineers defected to the AI company. OpenAI’s response was dismissive, framing the departures as a management failure rather than theft.

In Brazil, regulators are threatening fines of roughly 72,300 British pounds per day over demands for stricter age verification on gambling apps. For a company of Apple’s scale, the financial exposure is trivial — but the optics feed a narrative of a fortress under siege on several fronts at once.

The Chart’s Verdict: Neutral, With Limited Upside

The technical picture offers little clarity. At €272.30, the stock sits just 0.97 percent above its 50-day moving average of €269.68 — a level that signals neither breakout nor panic. The relative strength index of 46.6 confirms the neutral posture. The average analyst price target of €279.90 implies a modest 2.8 percent upside from current levels.

Over the past seven days, the shares have shed 5.96 percent, leaving them 9.77 percent below the 52-week high of €301.80 reached in July. For the year, however, the stock remains up roughly 16 percent.

Institutional positioning tells a mixed story. Resolute Wealth Strategies, Stillwater Private Wealth, Eaton Cambridge, and Lowe Brockenbrough all expanded their Apple holdings in the first quarter, some by more than 20 percent. Boston Common Asset Management, Liberty Square Wealth Partners, and Little House Capital trimmed their positions. Dividend investors will note that August 10 marks the ex-date for the next quarterly payout of $0.27 per share.

Until the DRAM bottleneck is resolved, the stock appears likely to remain in a consolidation phase. The record numbers are real — but they’re fighting an adversary that Apple can’t simply negotiate away this time.

Ad

Apple Stock: Buy or Sell?! New Apple Analysis from November 5 delivers the answer:

The latest Apple figures speak for themselves: Urgent action needed for Apple investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 5.

Apple: Buy or sell? Read more here...

Tags: Apple
Rodolfo Hanigan

Rodolfo Hanigan

Related Posts

Micron Technology Stock
AI & Quantum Computing

Micron’s Rally Faces Its Moment of Reckoning: A Downgrade, a Labor Standoff, and a Date With the Numbers

September 9, 2026
Almonty Stock
Asian Markets

Almonty’s Double Play: A $300 Million Buyback Lands as Sangdong’s Stockpile Grows

September 7, 2026
SAP Stock
Analysis

SAP’s Buyback Machine Grinds On, But the Analyst Chorus Is Turning Sour

September 7, 2026
Next Post
SANDISK Stock

SanDisk's Record Quarter Fails to Silence the Skeptics as Guidance Cools the Rally

Figma Stock

Figma Shares Tumble as AI Investment Costs Eclipse Blowout Revenue

Applovin Stock

AppLovin Shares Sink as Q3 Guidance Overshadows Another Strong Quarter

Recommended

indiemiconductor Stock

Indie Semiconductor Shares Face Technical Headwinds

1 year ago
BioNTech Stock

BioNTech Secures CureVac Acquisition in Landmark mRNA Deal

11 months ago
Food Retailers Market Capitalization

Victorias Secret Reports Strong Earnings Growth and Strategic Initiatives for Future Success

3 years ago

CNH Industrials Financial Report for Q4 2023 Meeting Expectations and Predicting a Slowdown in 2024

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Profits Show Up Beyond AI, Even When Deal Premiums Don’t

Pharma Pays for the Rotation While Crypto Hunts for a Floor

Tech Loses $1 Trillion, but the Rest of the Market Holds

Alphabet’s Cloud Doubles, Its Cash Turns Negative, the Stock Sinks

Margins Over Stories: Who Delivers Before the Fed and Big Tech

UPS and Coca-Cola Raise Guidance by Charging More, Not Selling More

Trending

Fastly Stock
Newsletter

Maersk Lifts Guidance a Third Time, and the Stock Still Sinks

by Stephanie Dugan
November 5, 2026
0

Dear readers, Raised guidance was supposed to be the safe harbor of earnings season. Maersk has tested...

AMD Stock

Democrats Win, and the Market Sorts Solar From Musk and Defense

November 4, 2026
Apple Stock

Good Quarters, Heavy Selling: Cash Flow Beats Growth on Election Day

November 3, 2026
Lumentum Stock

Profits Show Up Beyond AI, Even When Deal Premiums Don’t

November 2, 2026
Bitcoin Stock

Pharma Pays for the Rotation While Crypto Hunts for a Floor

October 31, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Maersk Lifts Guidance a Third Time, and the Stock Still Sinks
  • Democrats Win, and the Market Sorts Solar From Musk and Defense
  • Good Quarters, Heavy Selling: Cash Flow Beats Growth on Election Day

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com